METASTATIC HORMONE SENSITIVE PROSTATE CANCER
Clinical trials for METASTATIC HORMONE SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for prostate cancer patients: stronger treatment when first therapy fails
Disease control Not yet recruitingThis study is for men with advanced prostate cancer that has spread and responds to hormone therapy. It tests if adding chemotherapy (docetaxel) to their current treatment helps when their PSA levels haven't dropped enough after initial therapy. About 320 participants will be ran…
Matched conditions: METASTATIC HORMONE SENSITIVE PROSTATE CANCER
Phase: PHASE3 • Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Massive study to track Real-Life results for advanced prostate cancer treatment
Knowledge-focused Not yet recruitingThis study aims to understand how well a drug combination works for advanced prostate cancer in real-world settings, outside of controlled clinical trials. It will observe about 1,600 men in Europe who are already starting this treatment as part of their regular care. The main go…
Matched conditions: METASTATIC HORMONE SENSITIVE PROSTATE CANCER
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC